ArticlePolymers2026
Impact of Pre-Polymerization Thermal Modification on the Optical Resistance of Anterior Composites Against Thermal Cycling and Coffee Staining: An In Vitro Study.
Article in Polymers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Color instability in anterior composite restorations remains a primary cause for clinical replacement. While pre-polymerization thermal modification is increasingly utilized in daily practice, its precise impact on phase-specific and long-term optical resistance against continuous thermal aging and aggressive dietary staining remains unclarified. This in vitro study evaluated the impact of pre-polymerization thermal modification (4 °C, 23 °C, and 55 °C) on the phase-specific and cumulative color stability (ΔE
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.